You are here

secukinumab

Novartis' psoriasis drug tops J&J's Stelara as it speeds toward approval

Fierce Biotech

Fri, 12/12/14 - 08:51 am

Europe gives green light to AbbVie hepatitis C medicine, others

Yahoo/Reuters

Fri, 11/21/14 - 08:11 am

Boehringer Ingelheim

Novartis Announces Positive Phase-III Results For Secukinumab

Bidness Etc.

Thu, 10/23/14 - 08:38 am

ankylosing spondylitis

Benefits of Novartis psoriasis drug outweighs risk: FDA staff

Yahoo/Reuters

Thu, 10/16/14 - 09:19 am

Novartis Says Psoriasis Drug Met End-Goal of Arthritis Studies

Bloomberg

Thu, 09/25/14 - 07:38 am

psoriatic arthritis

Novartis' Phase III Results on Secukinumab Published

Yahoo/Zacks.com

Thu, 07/10/14 - 11:30 am

New class of psoriasis drugs being developed

Bloomberg

Fri, 10/4/13 - 10:14 am

Novartis' psoriasis drug superior to Enbrel in study

Reuters

Mon, 07/8/13 - 10:39 am